Top Upgrades
- Analysts at Macquarie upgraded Hawaiian Holdings, Inc. HA from Neutral to Outperform. Hawaiian shares rose 1.3 percent to $29.06 in pre-market trading.
- Raymond James upgraded Equity Residential EQR from Underperform to Market Perform. Equity Residential shares fell 0.8 percent to $75.74 in pre-market trading.
- JP Morgan upgraded Five Below Inc FIVE from Neutral to Overweight. Five Below shares rose 2.5 percent to $132.40 in pre-market trading.
- Analysts at Macquarie upgraded Crescent Point Energy Corp CPG from Neutral to Outperform. Crescent Point Energy shares rose 1 percent to $4.06 in pre-market trading.
- Morgan Stanley upgraded Hamilton Lane Inc HLNE from Equal-Weight to Overweight. Hamilton Lane shares gained 1.25 percent to close at $44.51 on Wednesday.
- Maxim Group upgraded Cracker Barrel Old Country Store, Inc. CBRL from Hold to Buy. Cracker Barrel shares rose 1.6 percent to $155.18 in pre-market trading.
Top Downgrades
- Stifel Nicolaus downgraded Waste Management, Inc. WM from Buy to Hold. Waste Management shares fell 1.3 percent to $101.64 in pre-market trading.
- Bank of America downgraded United States Steel Corporation X from Buy to Underperform. United States Steel shares fell 2.7 percent to $16.78 in pre-market trading.
- HSBC downgraded Mercadolibre Inc MELI from Buy to Hold. MercadoLibre shares fell 0.3 percent to $512.99 in pre-market trading.
- Oppenheimer downgraded Helius Medical Technologies Inc HSDT from Outperform to Perform. Helius Medical shares fell 66.18 percent to close at $2.10 on Tuesday.
- Guggenheim downgraded Eli Lilly And Co LLY from Buy to Neutral. Eli Lilly shares fell 1.1 percent to $125.84 in pre-market trading.
- Stifel Nicolaus downgraded Waste Connections Inc WCN from Buy to Hold. Waste Connections shares fell 1 percent to $87.55 in pre-market trading.
- Morgan Stanley downgraded Keurig Dr Pepper Inc KDP from Equal-Weight to Underweight. Keurig Dr Pepper shares fell 2.7 percent to $27.30 in pre-market trading.
- Barclays downgraded Fortune Brands Home & Security Inc FBHS from Equal-Weight to Underweight. Fortune Brands Home shares fell 0.2 percent to $49.57 in pre-market trading.
- Jefferies downgraded Chipotle Mexican Grill, Inc. CMG from Buy to Hold. Chipotle shares fell 1.2 percent to $710.11 in pre-market trading.
- Bank of America downgraded Lazard Ltd LAZ from Buy to Neutral. Lazard shares slipped 1.5 percent to $37.00 in pre-market trading.
Top Initiations
- Credit Suisse initiated coverage on Hewlett Packard Enterprise Co HPE with an Underperform rating. The price target for Hewlett Packard Enterprise is set to $14. Hewlett Packard Enterprise shares closed at $16.27 on Wednesday.
- RBC Capital initiated coverage on ArQule, Inc. ARQL with an Outperform rating. The price target for ArQule is set to $9. ArQule closed at $5.66 on Wednesday.
- Analysts at Bernstein initiated coverage on PTC Therapeutics, Inc. PTCT with an Outperform rating. The price target for PTC Therapeutics is set to $48. PTC Therapeutics shares closed at $38.66 on Wednesday.
- Stifel Nicolaus initiated coverage on Incyte Corporation INCY with a Hold rating. The price target for Incyte is set to $82. Incyte shares closed at $83.41 on Wednesday.
- Goldman Sachs initiated coverage on Cemex SAB de CV ADR CX with a Neutral rating. The price target for Cemex is set to $5.50. Cemex shares closed at $4.94 on Wednesday.
- Credit Suisse initiated coverage on Apple Inc. AAPL with a Neutral rating. The price target for Apple is set to $209. Apple shares closed at $200.62 on Wednesday.
- Analysts at BMO Capital initiated coverage on CVS Health Corp CVS with an Outperform rating. The price target for CVS Health is set to $58. CVS Health shares closed at $53.87 on Wednesday.
- Analysts at Cowen & Co. initiated coverage on Yeti Holdings Inc YETI with an Outperform rating. The price target for Yeti is set to $35. Yeti shares closed at $30.20 on Wednesday.
- Credit Suisse initiated coverage on IBM IBM with an Outperform rating. The price target for IBM is set to $173. IBM shares closed at $143.02 on Wednesday.
- Analysts at Stifel Nicolaus initiated coverage on Seattle Genetics, Inc. SGEN with a Hold rating. The price target for Seattle Genetics is set to $70. Seattle Genetics closed at $80.91 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in